Emergent BioSolutions | L'Utile Ante Imposte

Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Amarin USD -18810000 895K 2023-09
ANI Pharmaceuticals USD 27.68M 10.91M 2023-06
BioMarin Pharmaceutical USD 33.33M 8.34M 2023-12
Exact Sciences USD -50376000 51.42M 2023-12
Exelixis USD 103.04M 97.22M 2023-12
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Ironwood Pharmaceuticals USD 31.93M 33.93M 2023-09
Lonza CHF 508M 175M 2023-06
Merck USD -473000000 6.86B 2023-12
Moderna USD 70M 2.03B 2023-12
Myriad Genetics USD -2600000 6.6M 2023-09
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pacira USD 48.15M 121K 2023-09
Pfizer USD -1250000000 5.38B 2023-09
PTC Therapeutics USD -19493000 147.1M 2023-12
Sanofi EUR 3.96B 1.2B 2023-09
Sarepta Therapeutics USD -33174000 18.59M 2023-09
United Therapeutics USD 295.4M 56.4M 2023-12



Emergent BioSolutions L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.